TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  The Motley Fool

Patient Capital Bets Big on Precigen (PGEN) By Acquiring 10.2 Million Shares

The Motley Fool Logo The Motley Fool By Cory Renauer
Patient Capital Bets Big on Precigen (PGEN) By Acquiring 10.2 Million Shares

Patient Capital Management increased its stake in Precigen by 10.2 million shares in Q3 2025, valuing the transaction at approximately $28.78 million. The investment represents 3.48% of the fund's assets under management, following Precigen's significant stock price surge after FDA approval of Papzimeos.

Insights
MSpO   neutral

Analyst Mike Wilson provides varied scenarios from moderate pullback to potential recession, but notes earnings resilience


PGEN   positive

Stock up 375.91% over past year, received FDA full approval for Papzimeos, and attracted significant institutional investment from Patient Capital Management